reduced results from

147 billion

41 million

1 million

15252

to ~269 options

options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications

what is 'lymphokine-activated killer cell therapy'? Definition for Lymphokine-activated killer cell therapy Lymphokine-activated killer cell therapy is medication used for such diagnoses as: malignancy. diagnoses treated with 'lymphokine-activated killer cell therapy' 1 - 1 of 1 diagnosis malignancy cancer web search for: Lymphokine-activated killer cell therapy and malignancy related procedures when taking 'lymphokine-activated killer cell therapy' 1 - 5 of 186 procedures Abdominal CAT Scan web search for: Lymphokine-activated killer cell therapy and Abdominal CAT Scan Abdominal MRI MRI of abdominal contents web search for: Lymphokine-activated killer cell therapy and Abdominal MRI Array genomic hybridization web search for: Lymphokine-activated killer cell therapy and Array genomic hybridization Avoid Smoking web search for: Lymphokine-activated killer cell therapy and Avoid Smoking BUN web search for: Lymphokine-activated killer cell therapy and BUN Bacille Calmette-Guérin (BCG) web search for: Lymphokine-activated killer cell therapy and Bacille Calmette-Guérin (BCG) Beta-2 microglobulin web search for: Lymphokine-activated killer cell therapy and Beta-2 microglobulin Biopsy web search for: Lymphokine-activated killer cell therapy and Biopsy Biopsy skin web search for: Lymphokine-activated killer cell therapy and Biopsy skin Bladder tumor antigen (BTA) web search for: Lymphokine-activated killer cell therapy and Bladder tumor antigen (BTA) Brachytherapy Sealed source radiotherapy web search for: Lymphokine-activated killer cell therapy and Brachytherapy Brain MRI web search for: Lymphokine-activated killer cell therapy and Brain MRI Breast Self Exams web search for: Lymphokine-activated killer cell therapy and Breast Self Exams Brush Cytology web search for: Lymphokine-activated killer cell therapy and Brush Cytology CA 125 (cancer antigen 125) web search for: Lymphokine-activated killer cell therapy and CA 125 (cancer antigen 125) CA 15-3 (cancer antigen 15.3) web search for: Lymphokine-activated killer cell therapy and CA 15-3 (cancer antigen 15.3) CA 19-9 (cancer antigen 19-9) web search for: Lymphokine-activated killer cell therapy and CA 19-9 (cancer antigen 19-9) CA 27.29 ((cancer antigen 27.29) web search for: Lymphokine-activated killer cell therapy and CA 27.29 ((cancer antigen 27.29) CA 72-4 (cancer antigen 72-4) web search for: Lymphokine-activated killer cell therapy and CA 72-4 (cancer antigen 72-4) CT Guided Needle Biopsy web search for: Lymphokine-activated killer cell therapy and CT Guided Needle Biopsy for more please login, login is free (click to login) related medication for 'lymphokine-activated killer cell therapy' 1 - 5 of 82 drugs 5-fluorouracil (5-fu) web search for: Lymphokine-activated killer cell therapy and 5-fluorouracil (5-fu) 6-mercaptopurine (6-mp) web search for: Lymphokine-activated killer cell therapy and 6-mercaptopurine (6-mp) actinomycin-d web search for: Lymphokine-activated killer cell therapy and actinomycin-d alemtuzumab web search for: Lymphokine-activated killer cell therapy and alemtuzumab alkylating agents web search for: Lymphokine-activated killer cell therapy and alkylating agents altretamine web search for: Lymphokine-activated killer cell therapy and altretamine anastrozole web search for: Lymphokine-activated killer cell therapy and anastrozole anti tumor antibiotics web search for: Lymphokine-activated killer cell therapy and anti tumor antibiotics antimetabolites web search for: Lymphokine-activated killer cell therapy and antimetabolites arsenic trioxide web search for: Lymphokine-activated killer cell therapy and arsenic trioxide bevacizumab web search for: Lymphokine-activated killer cell therapy and bevacizumab bexarotene web search for: Lymphokine-activated killer cell therapy and bexarotene bicalutamide web search for: Lymphokine-activated killer cell therapy and bicalutamide bleomycin web search for: Lymphokine-activated killer cell therapy and bleomycin bortezomib web search for: Lymphokine-activated killer cell therapy and bortezomib busulfan web search for: Lymphokine-activated killer cell therapy and busulfan capecitabine web search for: Lymphokine-activated killer cell therapy and capecitabine carmustine (bcnu) web search for: Lymphokine-activated killer cell therapy and carmustine (bcnu) cetuximab web search for: Lymphokine-activated killer cell therapy and cetuximab chlorambucil web search for: Lymphokine-activated killer cell therapy and chlorambucil for more please login, login is free (click to login) The following are types of physicians relevant for 'Lymphokine-activated killer cell therapy'. related types of physicians 'family practitioner, internist, oncologist' show local physicians postal code Find Local stars represent relevance to topic not rating more The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested. web search results for 'lymphokine-activated killer cell therapy'? Results 1 - 50 - Lymphokine-activated killer cell therapy Interleukin 2 and lymphokine-activated killer cell therapy ... Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus ... Killer Cells, Lymphokine-Activated/immunology* Male. Melanoma/therapy ... http://www.ncbi.nlm.nih.gov/pubmed/2224862   www.ncbi.nlm.nih.gov - summary Human lymphokine-activated killer cells develop syngeneic ... Lymphokine-activated killer (LAK)-cell therapy has emerged as a new strategy in ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1385239   www.pubmedcentral.nih.gov - summary Interleukin-2 and lymphokine-activated killer cell therapy of ... Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: ... interleukin-2 (IL-2) and lymphokine-activated killer (LAK) cells in three phase ... http://www.ncbi.nlm.nih.gov/pubmed/2647914   www.ncbi.nlm.nih.gov - summary Induction of cytolytic activity in SIV(MAC)-infected Rhesus ... ... of non-MHC restricted lymphokine activated killer cells in Rhesus monkeys ... investigate the potential of lymphokine therapy in the management of ... http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102192306.html   gateway.nlm.nih.gov - summary Lymphokine-activated killer cytotoxicity against leukaemic ... ... N, Sabio H. Lymphokine-activated killer cell lysis of human neuroblastoma ... PD, Fefer A. Specific adoptive therapy of established leukemia with syngeneic ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1535230   www.pubmedcentral.nih.gov - summary Interleukin-2 lymphokine-activated killer cell therapy of non ... Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma ... Killer Cells, Lymphokine-Activated* Lymphoma, Non-Hodgkin/therapy ... http://www.ncbi.nlm.nih.gov/pubmed/2043594   www.ncbi.nlm.nih.gov - summary Interleukin-2-inducible natural immune (lymphokine-activated ... The groups receiving AZT therapy had fewer CD4+ cells but lower circulating p24 ... Diminution of inducible lymphokine-activated killer cell activity in individuals ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?blobtype=html&artid=368333   www.pubmedcentral.nih.gov - summary Pathogenesis of autoimmune hypothyroidism induced by ... ... by lymphokine-activated killer (LAK) cell therapy: in vitro ... Lymphokine-activated killer (LAK) cell therapy frequently results in primary hypothyroidism. ... http://www.ncbi.nlm.nih.gov/pubmed/8257856   www.ncbi.nlm.nih.gov - summary LAK cell Prev Term: Lagothrix. Next Term: LAK therapy. LAK cell. See: lymphokine activated killer cell. Send your comments to: Melody Lowe ... http://crisp.cit.nih.gov/Thesaurus/00013400.htm   crisp.cit.nih.gov - summary Lysis of primary hepatic tumours by lymphokine activated ... Lymphokine activated killer cell is a newly described lytic system against a ... PD, Fefer A. Specific adoptive therapy of established leukemia with syngeneic ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1432967   www.pubmedcentral.nih.gov - summary Autologous lymphokine-activated killer cell therapy of ... Autologous lymphokine-activated killer cell therapy of lymphoproliferative ... Killer Cells, Lymphokine-Activated* Liver Transplantation. Lung Transplantation ... http://www.ncbi.nlm.nih.gov/pubmed/9142315   www.ncbi.nlm.nih.gov - summary Renal Cell Cancer ... 2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. ... in second-line therapy for patients with metastatic renal cell carcinoma (RCC) ... http://www.webmd.com/cancer/tc/ncicdr0000062894-stage-iv-and...   www.webmd.com - summary Immunotherapy with lymphokine-activated natural killer cells ... Carcinoma, Renal Cell/secondary. Carcinoma, Renal Cell/therapy* Cell Separation. Female ... Kidney Neoplasms/therapy* Killer Cells, Lymphokine-Activated/immunology ... http://www.ncbi.nlm.nih.gov/pubmed/2074441   www.ncbi.nlm.nih.gov - summary Indirect inhibition of generation of murine lymphokine ... Augmentation of murine lymphokine (rIL-2)-activated killer cell activity by indomethacin. ... lung metastasis in mice by chronic indomethacin therapy combined ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1384091   www.pubmedcentral.nih.gov - summary Microsoft Word - NCI Manuscript_FINAL 10-4-07.doc ... T cell proliferation and the induction of lymphokine-activated killer cells. ... IL-7 therapy dramatically alters peripheral T cell homeostasis in normal and SIV ... http://dcb.nci.nih.gov/ImmunAgentWork/Details_Tcell_Growth_Factors.cfm   dcb.nci.nih.gov - summary Continuous infusion of recombinant interleukin-2 with or ... ... lymphokine activated killer cells for the treatment of advanced renal cell carcinoma. ... therapy* Killer Cells, Lymphokine-Activated/transplantation ... http://www.ncbi.nlm.nih.gov/pubmed/1627369   www.ncbi.nlm.nih.gov - summary Cardiomyopathy associated with high-dose interleukin-2 therapy. ... with advanced cancer using lymphokine-activated killer cells and interleukin-2 ... Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1002997   www.pubmedcentral.nih.gov - summary The influence of protein malnutrition on T cell, natural ... Killer Cells, Lymphokine-Activated/immunology* Killer Cells, Natural/immunology ... Neoplasms, Experimental/therapy. Protein Deficiency/immunology ... http://www.ncbi.nlm.nih.gov/pubmed/2141553   www.ncbi.nlm.nih.gov - summary Combination chemo-immunotherapy: kinetics of in vivo and in ... ... 2 (IL-2) induced lymphokine-activated killer (LAK) cell activity was examined. ... Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1534943   www.pubmedcentral.nih.gov - summary Lymphokine-activated killer T-cell-originated protein kinase ... Melanoma cell lines with high levels of TOPK are more ... Killer Cells, Lymphokine-Activated/enzymology* Mass Spectrometry/methods. Melanoma/drug therapy ... http://www.ncbi.nlm.nih.gov/pubmed/17145805?ordinalpos=3&ito...   www.ncbi.nlm.nih.gov - summary In vivo boosting of lung natural killer and lymphokine ... ... were comparable to systemic (splenic) NK activity following the same therapy. ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1535147   www.pubmedcentral.nih.gov - summary Phase Ib trial of pentoxifylline and ciprofloxacin in ... ... IL-2 and lymphokine-activated killer cell (LAK) cell therapy for metastatic ... Kidney Neoplasms/therapy* Killer Cells, Lymphokine-Activated/transplantation* Male ... http://www.ncbi.nlm.nih.gov/pubmed/8012963   www.ncbi.nlm.nih.gov - summary Selective modulation of human natural killer cells in vivo ... ... Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: ... A. Natural killer and lymphokine-activated killer cell activities from human ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=330005   www.pubmedcentral.nih.gov - summary Synergistic effect of Nocardia rubra cell wall skeleton and ... ... inoculated i.p. with 3LL tumor cells were treated by local combination therapy ... prolonged their survival and augmented lymphokine-activated killer (LAK) ... http://www.ncbi.nlm.nih.gov/pubmed/1833049   www.ncbi.nlm.nih.gov - summary Long-term cultures of human peripheral blood lymphocytes with ... ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... therapy: predominant role for lymphocytes with increased expression of CD2 and ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1535142   www.pubmedcentral.nih.gov - summary HER2-specific cytotoxic activity of lymphokine-activated ... ... HER2-specific cytotoxic activity on lymphokine-activated killer (LAK) cells. ... Breast Neoplasms/therapy. Cell Line, Tumor. Cytotoxicity, Immunologic. Humans ... http://www.ncbi.nlm.nih.gov/pubmed/15868915   www.ncbi.nlm.nih.gov - summary Low-dose cyclophosphamide and low-dose interleukin-2 for ... ... lymphokine activated killer cells, and was more tolerable than therapy with high ... Lymphokine-activated killer cell phenomenon. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1807785   www.pubmedcentral.nih.gov - summary Composite effects of group drumming music therapy on ... ... natural killer cell activity, lymphokine-activated killer cell activity, plasma ... Killer Cells, Lymphokine-Activated/metabolism. Male. Music Therapy ... http://www.ncbi.nlm.nih.gov/pubmed/11191041   www.ncbi.nlm.nih.gov - summary Melanoma-specific cytotoxic T cells generated from peripheral ... ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... combined recombinant interleukin-2 and LAK cell therapy. J Clin Oncol. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?&artid=1357828   www.pubmedcentral.nih.gov - summary Use of N-acetyl cysteine to increase intracellular ... IL-2 therapy can induce marked oxidative stress via reactive oxygen and nitrogen ... levels during lymphokine-activated killer (LAK) cell activation by IL ... http://www.ncbi.nlm.nih.gov/pubmed/8207209   www.ncbi.nlm.nih.gov - summary Characteristics of ex vivo propagated autologous CD8+ T-cells ... ... killer (K562) and lymphokine-activated killer cell (DAUDI) ... Killer Cells, Lymphokine-Activated. Phytohemagglutinins. T-Lymphocytes. immunology. therapy ... http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102198201.html   gateway.nlm.nih.gov - summary Defective interleukin-2 induction of lymphokine-activated ... ... blood T lymphocytes contain lymphokine-activated killer cell precursors. Eur J Immunol. ... A) as post-induction therapy for responding multiple myeloma ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1534718   www.pubmedcentral.nih.gov - summary High mobility group box I (HMGB1) release from tumor cells ... ... lymphokine activated killer cell activity is not dependent solely on the mode of cell death. ... metabolism. Colonic Neoplasms. Combined Modality Therapy ... http://www.ncbi.nlm.nih.gov/pubmed/17667523?ordinalpos=18&it...   www.ncbi.nlm.nih.gov - summary Lysis of colonic epithelial cells by allogeneic mononuclear ... Neither drug therapy nor disease activity influenced the results. ... Lymphokine-activated and natural killer cell activity in human intestinal mucosa. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1433892   www.pubmedcentral.nih.gov - summary Evaluation of a Superoxide Dismutase Mimetic As an Adjunct to ... M40403 and Lymphokine-Activated Killer (LAK) Cell Activation. Figure 8 ... Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: ... http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=eurekah&part=A34482   www.ncbi.nlm.nih.gov - summary Changes in natural immunity during the course of HIV-1 infection. ... combined recombinant interleukin-2 and LAK cell therapy. J Clin Oncol. ... Diminution of inducible lymphokine-activated killer cell activity in individuals ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1554830   www.pubmedcentral.nih.gov - summary Ganoderma lucidum polysaccharides enhance the function of ... ... 5, as well as NK cell and lymphokine activated killer cell activity on days 7-9. ... efficacious adjacent immunopotentiating therapy against cancer chemotherapy ... http://www.ncbi.nlm.nih.gov/pubmed/17182202   www.ncbi.nlm.nih.gov - summary In vivo treatment with interferon causes augmentation of IL-2 ... ... the mechanism of synergy we have studied lymphokine-activated killer (LAK) cell ... Combination therapy with interleukin-2 and alpha-interferon for the ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1535732   www.pubmedcentral.nih.gov - summary A murine model for the immunotherapy of head and neck ... Carcinoma, Squamous Cell/immunology. Carcinoma, Squamous Cell/therapy ... Killer Cells, Lymphokine-Activated/immunology. Lung Neoplasms/immunology ... http://www.ncbi.nlm.nih.gov/pubmed/7564839?ordinalpos=27&ito...   www.ncbi.nlm.nih.gov - summary Deficiency in circulating natural killer (NK) cell subsets in ... T cell cytotoxicity is not suppressed, but lymphokine-activated killer cell (LAK) ... Two patients were on intramuscular immunoglobulin therapy. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1905722   www.pubmedcentral.nih.gov - summary Immuno-modulatory effects of relaxation training and guided ... ... of CD25+ (activated T cells) and CD56+ (LAK cell) subsets. ... Killer Cells, Lymphokine-Activated/chemistry. Killer Cells, Natural/chemistry. Middle Aged ... http://www.ncbi.nlm.nih.gov/pubmed/19008099   www.ncbi.nlm.nih.gov - summary Aspergillus fumigatus contamination of lymphokine-activated ... Lymphokine-activated killer (LAK) cells, prepared by incubating autologous ... Fungi in fluids--a hazard of intravenous therapy. J Med Microbiol. 1970 Feb;3(1):99?102. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=269930   www.pubmedcentral.nih.gov - summary Human recombinant IL-4 suppresses the induction of human IL-2 ... ... vitro of human lymphokine activated killer cell (LAK) activity was investigated. ... impact of immunobiotechnology on cancer therapy. Br J Surg. 1987 Aug;74 ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?&artid=1541809   www.pubmedcentral.nih.gov - summary A combination therapy of gemcitabine with immunotherapy for ... OBJECTIVES: Dendritic cell (DC) therapy frequently induces a measurable immune response. ... of lymphokine-activated killer cells stimulated with anti-CD3 monoclonal ... http://www.ncbi.nlm.nih.gov/pubmed/19276867   www.ncbi.nlm.nih.gov - summary Tyrosine kinase-dependent and -independent events induced by ... ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... Lotzová E. Interleukin-2, killer cells and cancer therapy: an overview. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1383899   www.pubmedcentral.nih.gov - summary Natural killer cells and gamma delta T cells in scleroderma ... ... sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy. ... Lymphokine activated killer (LAK) cell activity in the peripheral blood ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1005516   www.pubmedcentral.nih.gov - summary Natural killer cell lines kill autologous ?2-microglobulin ... ... T cell fraction derived from heterologous lymphokine activated killer cells ... effects for specific T cell therapy, i.e., activated NK cells are a major ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24276   www.pubmedcentral.nih.gov - summary ADOPTIVE-CELL-TRANSFER THERAPY FOR THE TREATMENT OF PATIENTS ... ... ACTIVATED KILLER ... Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... with lymphokine-activated killer cells for the treatment of patients ... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2305722/?tool=pubmed   www.ncbi.nlm.nih.gov - summary Antibody-targeted interleukin 2 stimulates T-cell killing of ... ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... I, Rosenberg SA. Effect of combined therapy with lymphokine-activated ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=48464   www.pubmedcentral.nih.gov - summary Activated allogeneic cell therapy (allo-ACT) for relapsed ... Activated allogeneic cell therapy (allo-ACT) for relapsed ... Killer Cells, Lymphokine-Activated/transplantation* Leukemia, Myeloid, Accelerated Phase/therapy ... http://www.ncbi.nlm.nih.gov/pubmed/8971387   www.ncbi.nlm.nih.gov - summary show more 1  2

Chat with eNurse Kim about 'Lymphokine-activated killer cell therapy' or something else! quick facts related diagnosis category oncology